• Je něco špatně v tomto záznamu ?

Secretion of severe acute respiratory syndrome coronavirus 2 in urine

S. Brönimann, K. Rebhan, U. Lemberger, V. Misrai, SF. Shariat, B. Pradere,

. 2020 ; 30 (5) : 735-739. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20024794

PURPOSE OF REVIEW: Despite the plethora of publications discussing the severe respiratory coronavirus 2 (SARS-CoV-2), evidence of viral secretion in urine is sparse. RECENT FINDINGS: We could identify 34 publications including a total of 2172 patients. Among those, 549 patients were tested for SARS-CoV-2 secretion in urine, which was detected in only 38 patients (6.9%). Within the seven studies displaying positive results, the majority of positive patients (86.8%) was from not yet peer-reviewed studies including weak data and heterogeneous techniques for sample testing. Furthermore, none of the studies available in the literature addressed the virulence of detected viral RNA in urine. SUMMARY: Overall, only seven studies were able to detect SARS-CoV-2 secretion in urine, all of them with a considerably low rate of positivity. However, these studies were of rather low quality considering their methodology. Despite this, as SARS-CoV-2 has been detected in urine, it is of importance to discuss safety and urinary hygiene protocols. Until further research provides valid data on viral shedding and virulence in urine, potential risk of transmission through urine cannot be ruled out. Therefore, safety and hygiene measures need to be discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20024794
003      
CZ-PrNML
005      
20201222154921.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MOU.0000000000000808 $2 doi
035    __
$a (PubMed)32701726
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Brönimann, Stephan $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
245    10
$a Secretion of severe acute respiratory syndrome coronavirus 2 in urine / $c S. Brönimann, K. Rebhan, U. Lemberger, V. Misrai, SF. Shariat, B. Pradere,
520    9_
$a PURPOSE OF REVIEW: Despite the plethora of publications discussing the severe respiratory coronavirus 2 (SARS-CoV-2), evidence of viral secretion in urine is sparse. RECENT FINDINGS: We could identify 34 publications including a total of 2172 patients. Among those, 549 patients were tested for SARS-CoV-2 secretion in urine, which was detected in only 38 patients (6.9%). Within the seven studies displaying positive results, the majority of positive patients (86.8%) was from not yet peer-reviewed studies including weak data and heterogeneous techniques for sample testing. Furthermore, none of the studies available in the literature addressed the virulence of detected viral RNA in urine. SUMMARY: Overall, only seven studies were able to detect SARS-CoV-2 secretion in urine, all of them with a considerably low rate of positivity. However, these studies were of rather low quality considering their methodology. Despite this, as SARS-CoV-2 has been detected in urine, it is of importance to discuss safety and urinary hygiene protocols. Until further research provides valid data on viral shedding and virulence in urine, potential risk of transmission through urine cannot be ruled out. Therefore, safety and hygiene measures need to be discussed.
650    _2
$a Betacoronavirus $x izolace a purifikace $7 D000073640
650    _2
$a koronavirové infekce $x moč $7 D018352
650    _2
$a lidé $7 D006801
650    _2
$a pandemie $7 D058873
650    _2
$a virová pneumonie $x moč $7 D011024
650    12
$a vylučování virů $7 D017201
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Rebhan, Katharina $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Lemberger, Ursula $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Misrai, Vincent $u Department of Urology, Clinique Pasteur, Toulouse, France.
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Departments of Urology, Weill Cornell Medical College, New York, New York. Department of Urology, University of Texas Southwestern, Dallas, Texas, USA. Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia. Department of Urology, University of Jordan, Amman, Jordan. European Association of Urology Research Foundation, Arnhem, the Netherlands. Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.
700    1_
$a Pradere, Benjamin $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Department of Urology, CHRU Tours, Francois Rabelais University, Tours, France.
773    0_
$w MED00001296 $t Current opinion in urology $x 1473-6586 $g Roč. 30, č. 5 (2020), s. 735-739
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32701726 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154917 $b ABA008
999    __
$a ok $b bmc $g 1598939 $s 1115480
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 30 $c 5 $d 735-739 $e - $i 1473-6586 $m Current opinion in urology $n Curr Opin Urol $x MED00001296
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace